NON-SEGMENTAL VITILIGO (NSV)
Clinical trials for NON-SEGMENTAL VITILIGO (NSV) explained in plain language.
Never miss a new study
Get alerted when new NON-SEGMENTAL VITILIGO (NSV) trials appear
Sign up with your email to follow new studies for NON-SEGMENTAL VITILIGO (NSV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cream-and-Steroid combo aims to recolor vitiligo patches
Disease control Not yet recruitingThis study tests whether a cream containing ruxolitinib (Opzelura) combined with corticosteroid injections or pills can improve facial vitiligo. It includes people aged 12 and older with active, non-segmental vitiligo affecting the face. Participants use the cream twice daily and…
Matched conditions: NON-SEGMENTAL VITILIGO (NSV)
Sponsor: ShanShan Li • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New pill could help restore skin color in vitiligo patients
Disease control Not yet recruitingThis study tests an experimental drug called D-2570 in 160 adults with non-segmental vitiligo, a condition that causes white patches on the skin. Participants take either D-2570 or a placebo pill once daily for 24 weeks, with an optional 24-week extension. The goal is to see if t…
Matched conditions: NON-SEGMENTAL VITILIGO (NSV)
Phase: PHASE2 • Sponsor: InventisBio Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New pill aims to restore skin color in vitiligo patients
Disease control Not yet recruitingThis study tests an experimental pill called LW402 in 180 adults with non-segmental vitiligo, a condition that causes white patches on the skin. The pill works by blocking certain immune signals. Participants will take one of three doses or a placebo for up to 52 weeks to see if …
Matched conditions: NON-SEGMENTAL VITILIGO (NSV)
Phase: PHASE2 • Sponsor: Shanghai Longwood Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC